Illumina Ventures illuminaventures.com

Illumina Ventures pursues investments in early stage companies that are pioneering new applications of nucleic acid sequencing, developing products that will expand the genomics ecosystem, and utilizing genomics to improve human health.

Illumina Ventures pursues investments in early stage companies that are pioneering new applications of nucleic acid sequencing, developing products that will expand the genomics ecosystem, and utilizing genomics to improve human health.

See All Exits Recent Exits

Phone: 858-210-1824

Fax:

499 Illinois Street
Suite 210
 San Francisco, 94158
 California, United States

Illumina Ventures - Investments & Acquisitions

Show Real Data Illumina Ventures Investments
See all Recent Investments
Date Company Round Amount Co-investors
2021-01-12Delfi DiagnosticsSeries A$100MAV8 Ventures, Cowen, Foresite Capital, Menlo Ventures, Northpond Ventures, OrbiMed Advisors, Rock Springs Capital, Samsara BioCapital, T. Rowe Price, and Windham Venture Partners
2020-11-19Rebus BiosystemsSeries B$20MCTK Investment, LabGenomics, Lifecore Partners, NCORE VENTURES, RAY Company, Seegene, TIMEFOLIO Asset Management, and XOLON INVEST
2020-11-16IridiaSeries B$18MConnecticut Innovations
2020-09-11SerimmuneSeries C$12.05M
2020-07-29DNA ScriptSeries B - II$50MAgilent Technologies, Bpifrance, Casdin Capital, Danaher, Life Sciences Partners, and M Ventures
See all 5 investments